Novel antipsychotic medications and the treatment of comorbid substance abuse in schizophrenia (Q74485171)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9561949%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

Novel antipsychotic medications and the treatment of comorbid substance abuse in schizophrenia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9561949%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

substance abuse in schizophrenia

1 reference

1 reference

P F Buckley

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9561949%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 March 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9561949%20AND%20SRC:MED&resulttype=core&format=json

Journal of Substance Abuse Treatment

11 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9561949%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9561949%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9561949%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

113-116

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9561949%20AND%20SRC:MED&resulttype=core&format=json

Substance abuse in schizophrenia: service utilization and costs

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900134-7

7 January 2021

Psychotogenic drug use and neuroleptic response

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900134-7

7 January 2021

Clozapine and risperidone: refining and extending their use.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900134-7

7 January 2021

Patient response and resource management: another view of clozapine treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900134-7

7 January 2021

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900134-7

7 January 2021

Acute effects of drug abuse in schizophrenic patients: clinical observations and patients' self-reports

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900134-7

7 January 2021

The effect of long-term treatment with clozapine in schizophrenia: a retrospective study in 96 patients treated with clozapine for up to 13 years

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900134-7

7 January 2021

Amperozide, a 5-HT2 antagonist, attenuates craving for cocaine by rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900134-7

7 January 2021

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900134-7

7 January 2021

Integrated services for treatment of schizophrenic substance abusers: demographics, symptoms, and substance abuse patterns

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900134-7

7 January 2021

Ondansetron and opiate craving. A novel pharmacological approach to addiction.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900134-7

7 January 2021

Pharmacological treatment of substance-abusing schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900134-7

7 January 2021

Maintenance imipramine therapy for secondary depression in schizophrenia. A controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900134-7

7 January 2021

Schizophrenia and substance abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900134-7

7 January 2021

Impact of substance abuse on the course and outcome of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900134-7

7 January 2021

Comorbidity of schizophrenia and substance abuse: implications for treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900134-7

7 January 2021

10.1016/S0740-5472(97)00134-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9561949%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference